A comparative study of the protein C pathway in septic and nonseptic patients with organ failure
Borgel D, Bornstain C, Reitsma PH et al.
Am J Respir Crit Care Med 2007;176:878–85.
SECTION: RESEARCH
|
Adrenal response in patients with septic shock of abdominal origin: relationship to survival
Riché F, Boutron C, Valleur P et al.
Intensive Care Med 2007;33:1761–6.
SECTION: CLINICAL OBSERVATIONS AND RESEARCH
|
Cardiac morphological and functional changes during early septic shock: a transesophageal echocardiographic study
Etchecopar-Chevreuil C, François B, Clavel M et al.
Intensive Care Med 2008;34:250–6.
SECTION: CLINICAL OBSERVATIONS AND RESEARCH
|
Early enteral supplementation with key pharmaconutrients improves Sequential Organ Failure Assessment score in critically ill patients with sepsis: outcome of a randomized, controlled, double-blind trial
Beale RJ, Sherry T, Lei K et al.
Crit Care Med 2008;36:131–44.
SECTION: CLINICAL TRIALS
|
Effect of activated protein C on pulmonary blood flow and cytokine production in experimental acute lung injury
Richard JC, Bregeon F, Leray V et al.
Intensive Care Med 2007;33:2199–206.
SECTION: THERAPEUTICS RESEARCH
|
Oxygen consumption of human peripheral blood mononuclear cells in severe human sepsis
Belikova I, Lukaszewicz AC, Faivre V et al.
Crit Care Med 2007;35:2702–8.
SECTION: RESEARCH
|
Persistent villi hypoperfusion explains intramucosal acidosis in sheep endotoxemia
Dubin A, Edul VS, Pozo MO et al.
Crit Care Med 2008;36:535–42.
SECTION: RESEARCH
|
Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis
Li Y, Cui X, Li X et al.
Intensive Care Med 2008;34:568–77.
SECTION: RESEARCH
|
Score-based immunoglobulin G therapy of patients with sepsis: the SBITS study
Werdan K, Pilz G, Budjoso O et al.
Crit Care Med 2007;35:2693–701.
SECTION: CLINICAL TRIALS
|
Sepsis mortality prediction based on predisposition, infection and response
Moreno R, Metnitz B, Adler L et al.
Intensive Care Med 2008;34:496–504.
SECTION: CLINICAL OBSERVATIONS AND RESEARCH
|
Short-term beneficial effects of methylene blue on kidney damage in septic shock patients
Heemskerk S, van Haren FM, Foudraine NA et al.
Intensive Care Med 2008;34:350–4.
SECTION: THERAPEUTICS RESEARCH
|
Surviving meningococcal septic shock: health consequences and quality of life in children and their parents up to 2 years after pediatric intensive care unit discharge
Buysse CM, Raat H, Hazelzet JA et al.
Crit Care Med 2008;36:596–602.
SECTION: CLINICAL OBSERVATIONS AND RESEARCH
|
Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial
Nobre V, Harbarth S, Graf JD et al.
Am J Respir Crit Care Med 2008;177:498–505.
SECTION: CLINICAL TRIALS
|
Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis
Lange M, Ertmer C, Westphal M.
Intensive Care Med 2008;34:821–32.
SECTION: THERAPEUTICS RESEARCH
|
